Lanean...

MDM2, MDMX and p53 in oncogenesis and cancer therapy

The MDM2 and MDMX (also known as HDMX and MDM4) proteins are deregulated in many human cancers and exert their oncogenic activity predominantly by inhibiting the p53 tumour suppressor. However, the MDM proteins modulate and respond to many other signalling networks in which they are embedded. Recent...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wade, Mark, Li, Yao-Cheng, Wahl, Geoffrey M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161369/
https://ncbi.nlm.nih.gov/pubmed/23303139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc3430
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!